Lipid tail heterogeneity enables organ-selective mRNA delivery for in vivo CRISPR-Cas9 gene editing
Jing Liao, Jinjin Chen, Zhongfeng Ye(Tufts University), Fuguo Liu(Shanghai East Hospital), Zixi Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Yingsen Tang, Meng Jiang, Joseph Harmon, Qian Shen, Hangping Liao, Ling Zeng, Xinxiu Cao, Hui Fan, Yupeng Ren(Southwest Minzu University)
Cited by 0
Related Papers
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response
|Proceedings of the National Academy of Sciences|2022|411
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of <i>Angptl3</i>
|Proceedings of the National Academy of Sciences|2021|390
In situ cancer vaccination using lipidoid nanoparticles
|Science Advances|2021|117
In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
|ACS Biomaterials Science & Engineering|2022|104